(14153283), M. J. P., (4705993), E. W., (14153286), D. H., (14153289), B. S. G., & (8335038), E. T. A. (2019). Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> and CD4<sup>+</sup>CD25<sup>−</sup>Foxp3<sup>+</sup> T cells.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(14153283), Magdalena J. Polanczyk, Edwin Walker (4705993), Daniel Haley (14153286), Bella S. Guerrouahen (14153289), و Emmanuel T. Akporiaye (8335038). Blockade of TGF-β Signaling to Enhance the Antitumor Response Is Accompanied by Dysregulation of the Functional Activity of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> and CD4<sup>+</sup>CD25<sup>−</sup>Foxp3<sup>+</sup> T Cells. 2019.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(14153283), Magdalena J. Polanczyk, et al. Blockade of TGF-β Signaling to Enhance the Antitumor Response Is Accompanied by Dysregulation of the Functional Activity of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> and CD4<sup>+</sup>CD25<sup>−</sup>Foxp3<sup>+</sup> T Cells. 2019.